| |
|
|
|
Caladrius Biosciences Inc.  
|
|
4.5201 -0.26 (-0.05%) |
12-14 14:18 |
|
Open: |
4.76 |
Pre close: |
4.78 |
Target:
|
5.73 
|
|
High: |
4.82 |
Low: |
4.51 |
Resistance:
|
4.90
5.40
|
|
Volume: |
10,255 |
Market Cap: |
44M |
Support:
|
4.10
3.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.80
|
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
4.69 |
Signal(12,26,9): |
-0.01  |
|
MA(100): |
5.05 |
Stochastic Oscillator |
%K(14,3):
|
58.95 |
|
MA(250): |
4.84 |
%D(3): |
63.27 |
|
Average Volume(K) |
3-Month: |
3695
|
52-Week |
High:
|
11.65 |
|
10-Days: |
1734 |
Low: |
3.25 |
|
RSI |
RSI(14):
|
48.36 |
Change(%): |
35.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.700 |
Return on Equity (ttm) |
-32.8 |
Shares Out. (M) |
9.84 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
-26.8 |
Shares Float (M) |
1.98 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
83.00 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.40 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.130 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.76 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
